Cas:127919-31-7 ethyl 5-(4-fluorophenyl)-1,3-oxazole-4-carboxylate manufacturer & supplier

Chemical Name:ethyl 5-(4-fluorophenyl)-1,3-oxazole-4-carboxylate

CAS.NO:127919-31-7

Synonyms:ethyl 5-(4-fluorophenyl)-1,3-oxazole-4-carboxylate

Molecular Formula:C₁₂H₁₀FNO₃

Molecular Weight:235.21100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:52.33000

Exact Mass:235.06400

LogP:2.65740

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like ethyl 5-(4-fluorophenyl)-1,3-oxazole-4-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 5-(4-fluorophenyl)-1,3-oxazole-4-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ethyl 5-(4-fluorophenyl)-1,3-oxazole-4-carboxylate Use and application,ethyl 5-(4-fluorophenyl)-1,3-oxazole-4-carboxylate technical grade,usp/ep/jp grade.

Related News: Though Innova previously applied for a regulatory green light, the test has not been authorized or approved by the FDA for use in the U.S.—however, during inspections of the company’s California facilities in March and April, FDA investigators said they found the test was already being sold and distributed. ethyl 5-(4-fluorophenyl)-1,3-oxazole-4-carboxylate manufacturer On April 8, a group of employees filed an anonymous complaint internally alleging that an executive at its Branchburg, New Jersey, factory had altered documents required by the U.S. Food and Drug Administration. ethyl 5-(4-fluorophenyl)-1,3-oxazole-4-carboxylate supplier Though Innova previously applied for a regulatory green light, the test has not been authorized or approved by the FDA for use in the U.S.—however, during inspections of the company’s California facilities in March and April, FDA investigators said they found the test was already being sold and distributed. ethyl 5-(4-fluorophenyl)-1,3-oxazole-4-carboxylate vendor On April 8, a group of employees filed an anonymous complaint internally alleging that an executive at its Branchburg, New Jersey, factory had altered documents required by the U.S. Food and Drug Administration. ethyl 5-(4-fluorophenyl)-1,3-oxazole-4-carboxylate factory China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.